The Pleiotropic Actions of Adiponectin are Initiated via Receptor-Mediated Activation of Ceramidase Activity

Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Nature medicine (Impact Factor: 28.05). 01/2011; 17(1):55-63. DOI: 10.1038/nm.2277
Source: PubMed

ABSTRACT The adipocyte-derived secretory factor adiponectin promotes insulin sensitivity, decreases inflammation and promotes cell survival. No unifying mechanism has yet explained how adiponectin can exert such a variety of beneficial systemic effects. Here, we show that adiponectin potently stimulates a ceramidase activity associated with its two receptors, AdipoR1 and AdipoR2, and enhances ceramide catabolism and formation of its antiapoptotic metabolite--sphingosine-1-phosphate (S1P)--independently of AMP-dependent kinase (AMPK). Using models of inducible apoptosis in pancreatic beta cells and cardiomyocytes, we show that transgenic overproduction of adiponectin decreases caspase-8-mediated death, whereas genetic ablation of adiponectin enhances apoptosis in vivo through a sphingolipid-mediated pathway. Ceramidase activity is impaired in cells lacking both adiponectin receptor isoforms, leading to elevated ceramide levels and enhanced susceptibility to palmitate-induced cell death. Combined, our observations suggest a unifying mechanism of action for the beneficial systemic effects exerted by adiponectin, with sphingolipid metabolism as its core upstream signaling component.

Download full-text


Available from: Kai Sun, Aug 15, 2015
  • Source
    • "Moreover, adiponectin deficiency increased ceramide levels and exacerbated insulin resistance. Instead, activation of adiponectin receptors 1 and 2 stimulated sphingosine and sphingosine-1-phosphate synthesis, which improved insulin sensitivity and reduced metabolic inflammation (Holland et al. 2011b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Low-grade inflammation is an established pathological condition that contributes to the development of obesity, insulin resistance and type 2 diabetes. Metabolic inflammation is dependent on multiple signalling events. In an overnutrition state, canonical inflammatory pathways are induced by inflammatory cytokines and lipid species. They can also be triggered through inflammasome activation as well as through cellular stress provoked by the unfolded protein response at the endoplasmic reticulum as well as by reactive oxygen species. In this chapter, we summarize the current knowledge about signalling events within the cell and describe how they impact on metabolic inflammation and whole-body metabolism. We particularly highlight the interplay between different signalling pathways that link low-grade inflammation responses to the inactivation of the insulin receptor pathway, ultimately leading to insulin resistance, a hallmark of type 2 diabetes.
    Handbook of experimental pharmacology 04/2015; DOI:10.1007/164_2015_4
  • Source
    • "Therefore, inflammatory signals early after PHx likely promote increases in cellular ceramide, which have been observed after PHx (Alessenko et al, 1999). We expect this effect to be enhanced in Adn-/-mice because of the absence of Adn receptor-dependent ceramidase activity (Holland et al, 2011). Increased ceramide levels have also recently been linked to elevated levels of the tyrosine phosphatase SHP-1 (Gopalan et al, 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Following partial hepatectomy, the liver initiates a regenerative program involving hepatocyte priming and replication driven by coordinated cytokine and growth factor actions. We investigated the mechanisms underlying Adiponectin's (Adn) regulation of liver regeneration through modulation of these mediators. Adn-/- mice showed delayed onset of hepatocyte replication, but accelerated cell cycle progression relative to wild-type mice, suggesting Adn has multiple effects fine-tuning the kinetics of liver regeneration. We developed a computational model describing the molecular and physiological kinetics of liver regeneration in Adn-/- mice. We employed this computational model to evaluate the underlying regulatory mechanisms. Our analysis predicted that Adn is required for an efficient early cytokine response to partial hepatectomy, but is inhibitory to later growth factor actions. Consistent with this prediction, Adn knockout reduced hepatocyte responses to IL-6 during the priming phase, but enhanced growth factor levels through peak hepatocyte replication. By contrast, supraphysiological concentrations of Adn resulting from rosiglitazone treatment suppressed regeneration by reducing growth factor levels during S phase, consistent with computational predictions. Together, these results revealed that Adn fine-tunes the progression of liver regeneration through dynamically modulating molecular mediator networks and cellular interactions within the liver.This article is protected by copyright. All rights reserved
    The Journal of Physiology 11/2014; 593(2). DOI:10.1113/jphysiol.2014.284109 · 4.54 Impact Factor
  • Source
    • "So too has the role of sphingolipids such as ceramides and glucosylceramides as an important class of bioactive lipids, the accumulation of which has been implicated in a multitude of metabolic processes such as atherosclerosis, IR and diabetes [61], and as an important player in NAFLD and its progression to NASH [62]. Adiponectin is a potent stimulator of ceramidase activity and enhances ceramide catabolism [63]. Individuals with higher concentrations of adiponectin also present with lower cardiovascular risk [64] [65]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Adiponectin is the most abundant adipokine synthesized by adipose tissue and has been shown to be a key component in the relationship between adiposity, insulin resistance and inflammation. It circulates in plasma at physiological concentrations that represent 0.05% of all plasma proteins. Adiponectin has trimeric, hexameric and multimeric forms that bind to receptors AdipoR1, AdipoR2 and T-cadherin especially in liver, muscle and endothelial cells. Adiponectin is considered a potent modulator of lipid and glucose metabolism with antidiabetic, antiatherogenic and anti-inflammatory properties, and plays an important role in the pathogenesis of metabolic diseases. The hepatoprotective effects of adiponectin, especially in non-alcoholic fatty liver disease (NAFLD), have been widely investigated, and its antisteatotic, anti-inflammatory and antifibrogenic effects have already been described. Adiponectin levels are reduced in individuals with fatty liver disease independently of body mass index, insulin resistance and other adipokines, and are inversely related to the severity of steatosis and necroinflammation, suggesting an important role in the relationship between adipose tissue, the liver and insulin sensitivity. Adiponectin has also been found to be reduced in cases of hepatitis B and C infection, and in cholestatic and autoimmune diseases, but is increased in patients with cirrhosis of different aetiologies. In addition, an important role for the liver in the regulation of adiponectin secretion by adipocytes, mediated by bile acids, has recently been proposed. The present report describes the importance of adiponectin in hepatic diseases as well as some future perspectives of the role of adiponectin as a biomarker and therapeutic target in liver diseases.
    Diabetes & Metabolism 01/2014; 40(2). DOI:10.1016/j.diabet.2013.11.004 · 2.85 Impact Factor
Show more